Edward Stelmakh insider trades
Open-market stock purchases and sales by Edward Stelmakh, Chief Finance & Strat Officer at OptimizeRx Corp, from SEC Form 4 filings since Dec 19, 23.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -67%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Dec 23, 2025 | OPRX OptimizeRx Corp | Sold (not open market) | $46.6K |
| Dec 19, 2025 | OPRX OptimizeRx Corp | Sold (not open market) | $18.8K |
| Dec 19, 2025 | OPRX OptimizeRx Corp | Bought (not open market) | — |
| Dec 19, 2025 | OPRX OptimizeRx Corp | Bought (not open market) | — |
| Dec 19, 2025 | OPRX OptimizeRx Corp | Sold | $18.8K |
| Oct 3, 2025 | OPRX OptimizeRx Corp | Sold (not open market) | $82.6K |
| Oct 3, 2025 | OPRX OptimizeRx Corp | Bought (not open market) | — |
Companies traded
- OPRX OptimizeRx Corp: 1 buy, 1 sale, last Dec 23, 2025